Skip to content

17ohpserplmcnc

Published: August 9, 2026Updated: August 10, 2026

This test measures the level of 17-hydroxyprogesterone in the blood to screen for and monitor congenital adrenal hyperplasia (CAH), a genetic disorder affecting the adrenal glands.

Quick summary

{"17-OHP is a hormone produced by the adrenal glands","The test primarily screens for congenital adrenal hyperplasia (CAH)","It is commonly used in newborn screening programs","Elevated levels may indicate CAH, while low levels may suggest adrenal insufficiency","The test is performed on a blood sample, usually from a vein"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 10, 2026Editorial policy

Key facts at a glance

LOINC
1668-3
Short code
17-OHP, 17-OH Progesterone, 17-Hydroxyprogesterone
Synonyms
17OHP SerPl-mCnc
Category
chemistry
Sample
serum
Container
Serum Separator Tube (SST, gold top) or plain red top tube
Units
N/A
Ref low
0.2
Ref high
2.5
Critical range
— – 10 N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
Chemiluminescent Immunoassay (CLIA) or Enzyme-Linked Immunosorbent Assay (ELISA)
CPT
83498
SNOMED
31328002
Specimen volume
1.0-2.0 mL serum minimum
Stability
Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles.
Hemolysis max
50
Lipemia max
300
Icterus max
20
TAT
24–72 hours
Order
routine

What is this test?

The 17-hydroxyprogesterone (17-OHP) test measures the amount of 17-hydroxyprogesterone in your blood. 17-OHP is a hormone produced by the adrenal glands, which are small glands located on top of each kidney. This hormone is an intermediate product in the synthesis of cortisol, an important stress hormone that helps the body respond to illness, injury, and emotional stress.

Why is this test performed?

The primary purpose of the 17-OHP test is to screen for and diagnose congenital adrenal hyperplasia (CAH). CAH is a group of genetic disorders that affect the adrenal glands' ability to produce cortisol and often aldosterone (a hormone that regulates salt balance). In people with CAH, the body produces excessive amounts of 17-OHP due to enzyme deficiencies.

This test is commonly performed as part of newborn screening programs, which are routine tests done shortly after birth to detect certain genetic and metabolic disorders. Early detection of CAH is crucial because it allows for prompt treatment, which can prevent serious complications such as adrenal crisis, dehydration, and abnormal sexual development.

How is the test performed?

A healthcare professional will draw a blood sample from a vein in your arm (or from your baby's heel if it's a newborn screening). The blood sample is then sent to a laboratory for analysis. The test requires a small amount of blood, usually collected in a tube containing a clot activator or separator gel.

For newborns, the sample is often collected using a small prick on the heel. It is important to note that 17-OHP levels can be affected by various factors, including the time of day, stress, and certain medications. Therefore, your doctor may ask about these factors when interpreting the results.

What do the results mean?

Normal 17-OHP levels vary depending on age, gender, and the laboratory that performs the test. In general:

• Elevated 17-OHP levels: May indicate congenital adrenal hyperplasia (CAH). Further testing, such as genetic testing or ACTH stimulation test, may be needed to confirm the diagnosis and determine the specific type of CAH.

• Normal or low 17-OHP levels: Typically suggest that CAH is unlikely. However, in some cases of milder or late-onset CAH, levels may fall in the borderline range, requiring additional monitoring or testing.

Your healthcare provider will interpret your results in the context of your medical history, symptoms, and other test results. It is important to discuss any questions or concerns about your results with your doctor.

Are there any risks or preparations needed?

The 17-OHP test is a simple blood test with minimal risks. You may experience slight pain, bruising, or dizziness during or after the blood draw. These side effects are usually temporary and resolve on their own.

Generally, no special preparation (such as fasting) is required for this test. However, inform your healthcare provider about any medications, supplements, or herbal remedies you are taking, as some substances may affect the test results. Stress and illness can also influence 17-OHP levels, so let your doctor know if you are experiencing any health issues at the time of the test.

Reference range

Reference ranges vary by age, sex, and laboratory methodology. Typical adult male: 0.5-2.5 ng/mL; Adult female (follicular phase): 0.2-1.2 ng/mL; Adult female (luteal phase): 0.5-2.5 ng/mL; Newborns: may be elevated up to 10 ng/mL in first 48 hours; Children (1-12 months): 0.1-1.5 ng/mL; Children (1-10 years): 0.1-1.0 ng/mL. Consult laboratory-specific reference ranges.N/A

Specimen: serum

No fasting is required. Inform the laboratory of current medications, particularly glucocorticoids, estrogens, or androgen-containing medications that may affect results. Morning specimen preferred due to diurnal variation.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings4

Frequently asked questions

Is fasting required before the 17-OHP test?
No, fasting is typically not required for the 17-OHP test. However, it is important to follow any specific instructions provided by your healthcare provider. Inform your doctor about any medications, supplements, or health conditions that might affect the test results.
Can this test detect all types of CAH?
The 17-OHP test is most effective at detecting the classic form of CAH caused by 21-hydroxylase deficiency. It may not detect milder forms of CAH, such as non-classic CAH, which may present with normal or slightly elevated 17-OHP levels. Additional tests, including genetic testing, may be needed for a complete diagnosis.
What happens if my newborn's test is positive?
If the initial screening test shows elevated 17-OHP, it does not necessarily mean your baby has CAH. False positives can occur. Your healthcare provider will contact you for follow-up testing, which typically includes a repeat 17-OHP test and possibly other evaluations to confirm or rule out the diagnosis. Early diagnosis and treatment are important for managing CAH effectively.
How often should 17-OHP levels be monitored?
The frequency of monitoring depends on the individual patient's condition and treatment plan. For newborns and children with CAH, 17-OHP levels are typically checked every few months to ensure the medication dosage is appropriate. Adults with CAH may be monitored less frequently, usually annually or as symptoms change. Your doctor will determine the appropriate monitoring schedule for you or your child.
Are there any treatments for CAH?
Yes, CAH is a manageable condition. Treatment typically involves daily hormone replacement therapy with glucocorticoids (such as hydrocortisone, prednisone, or dexamethasone) to replace the cortisol the body cannot produce. In some cases, mineralocorticoids (like fludrocortisone) may also be needed. With proper treatment, individuals with CAH can lead healthy, normal lives. It is important to follow your treatment plan and attend regular follow-up appointments.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy